Of Cuffs and Custodians

Anne MacNamara The sight of Texas researcher Thomas Butler led away in handcuffs, an image broadcast across America earlier this year, shows that US regulators are serious about stricter laboratory security.1 Colleagues describe Butler, chief of the infectious disease division in the Texas Tech University Department of Internal Medicine, as a talented scientist long devoted to defeating plague. But the September 2001 terrorist attacks transformed plague from a scourge of the Third World into

Written byPeg Brickley
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

The sight of Texas researcher Thomas Butler led away in handcuffs, an image broadcast across America earlier this year, shows that US regulators are serious about stricter laboratory security.1 Colleagues describe Butler, chief of the infectious disease division in the Texas Tech University Department of Internal Medicine, as a talented scientist long devoted to defeating plague. But the September 2001 terrorist attacks transformed plague from a scourge of the Third World into a potential weapon of mass destruction in the eyes of regulators.

A federal grand jury indicted Butler last month on 15 counts, including smuggling, lying to federal agents, illegally transporting biohazards, and tax fraud, according to the Avalanche Journal of Lubbock, Texas. None of the charges target terrorism or suggest that Butler infected anyone with plague; nor do they allege that he violated new select-agent regulations that took effect in February. Butler faces allegations fashioned from tax laws ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies